Gf Fund Management Co. Ltd. 89bio, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in 89bio, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 2,469 shares of ETNB stock, worth $19,949. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,469Holding current value
$19,949% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ETNB
# of Institutions
172Shares Held
124MCall Options Held
78.7KPut Options Held
979K-
Janus Henderson Group PLC London, X016.5MShares$133 Million0.07% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$115 Million1.76% of portfolio
-
Suvretta Capital Management, LLC New York, NY10.2MShares$82.4 Million3.26% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$60.4 Million0.94% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$56.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $376M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...